The major proteoglycan in cartilage is of mobility. The OA disease causes a burden to society and the
aggrecan that is aided in its assembly into large molecules by healthcare system (30% of healthcare costs in the USA), but
the polysaccaride hyaluronan [4]. It is generally appreciated despite the increase in knowledge in medical science no drug-
that the cartilage matrix proteoglycan is constantly turned based disease modifying therapy exists [7], basically because
over with a long half-life for the collagen fibres (decades) and of the facts that (i) the disease process stretches over decades,
for a long time it was an established fact in the textbooks (ii) no biological markers able to monitor the early stages and
(e.g. in the 1937 Textbook of Histology by E. E. Hewer) that in the progression of OA exist and (iii) no specific drug target
the mature state the chondrocytes do not divide and thus are and disease mechanism have been identified.

unable to regenerate themselves and, even more unlikely, Secondary osteoarthritis, caused by joint trauma, tends to
repair a damaged tissue.